|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Five-year major clinical outcomes between first-generation ana second- generation drug-eluting stents in acute myocardial infarction patients underwent percutaneous coronary intervention显示文摘 | Yong Hoon Kim Ae-Young Her Seung-Woon Rha Byoung Geol Choi Se Yeon Choi Jae Kyeong Byun Ju Yeol Baek Woong Gil Choi Tae Soo Kang Ji Hoon Ahn Sang-Ho Park Ahmed Mashaly Jin Oh Na Cheol Ung Choi Hong Euy Lim Eung Ju Kim Chang Gyu Park Hong Seog Seo Dong Joo Oh | 2018 | Journal of Geriatric Cardiology2018，15，8： | 8 |
| 2 | Impact of old age on clinical and angiographic characteristics of coronary artery spasm as assessed by acetylcholine provocation test显示文摘吸烟并且另外的风险因素作为变体咽峡炎或冠的动脉痉挛(CAS ) 的重要因素众所周知。然而,与冠的动脉痉挛上的年龄有关的临床的特征是 evaluated.MethodsWe 很少与不足道的冠的动脉损害评估了 3155 个连续病人。病人们经历了醋胆素(Ach ) 为 CAS 的正式就职的挑衅测试。CAS 是被定义 >70% 钠在 Ach 期间变窄冠的动脉挑衅测试。Ach 挑衅测试的结果在年龄组之中被比较;< 45 年(组 1 ) , 45-54 年(组 2 ) , 55-64 年(组 3 ) ,和 .ResultsOlder 病人有高血压,糖尿病,而是更低的发生的更高的发生的 65 年(组 4 ) 与更年轻的病人相比当前的吸烟、男性别评价。积极 Ach 挑衅测试发现经常与老化被显示出(47.36% 对 58.3% 对 62.6% 对 61.5% ;P < 0.001 ) 。Multivariate 逻辑分析证明年龄,男性,和心肌的桥牌是学习显示出的在场的 Ach 挑衅 test.ConclusionOur 导致的 CAS 的独立预言者老年是为导致 Ach 的重要冠的动脉痉挛的独立预言者。 | Woong Gil Choi Soo Hyun Kim Seung-Woon Rha Kang-Yin CHEN Yong-Jian LI Byoung Geol Choi Se Yeon Choi Jin Won Kim Eung Ju Kim Chang Gyu Park Hong Seog Seo Dong Joo Oh | 2016 | Journal of Geriatric Cardiology2016，13，10： | 7 |
| 3 | High-dose hepatitis B immunoglobulin therapy in hepatocellular carcinoma with hepatitis B virus-DNA/hepatitis B e antigen-positive patients after living donor liver transplantation显示文摘AIM: To investigate the impact of high-dose hepatitis B immunoglobulin(HBIG) on hepatocellular carcinoma(HCC) and hepatitis B virus(HBV) recurrence and overall survival after living donor liver transplantation(LDLT).METHODS: We investigated 168 patients who underwent LDLT due to HCC, and who were HBV-DNA/hepatitis B e antigen(HBe Ag)-positive, from January 2008 to December 2013. After assessing whether the patients met the Milan criteria, they were assigned to the low-dose HBIG group and high-dose HBIG group. Using the propensity score 1:1 matching method, 38 and 18 pairs were defined as adhering to and not adhering to the Milan criteria. For each pair, HCC recurrence, HBV recurrence and overall survival were analyzed by the Kaplan-Meier method and the log rank test according to the HBIG dose. RESULTS: Among those who met the Milan criteria, the 6-mo, 1-year, and 3-year HCC recurrence-free survival rates were 88.9%, 83.2%, and 83.2% in the low-dose HBIG group and 97.2%, 97.2%, and 97.2% in the high-dose HBIG group, respectively(P = 0.042).In contrast, among those who did not meet the Milan criteria, HCC recurrence did not differ according to the HBIG dose(P = 0.937). Moreover, HBV recurrence and overall survival did not differ according to the HBIG dose among those who met(P = 0.317 and 0.190, respectively) and did not meet(P = 0.350 and 0.987, respectively) the Milan criteria. CONCLUSION: High-dose HBIG therapy can reduce HCC recurrence in HBV-DNA/HBe Ag-positive patients after LDLT. | Eung Chang Lee Seong Hoon Kim Seung Duk Lee Hyeongmin Park Soon-Ae Lee Sang-Jae Park | 2016 | World Journal of Gastroenterology2016，22，14： | 7 |
| 4 | Outcomes after liver transplantation in accordance with ABO compatibility: A systematic review and meta-analysis显示文摘AIM To evaluate the differences in outcomes between ABOincompatible(ABO-I) liver transplantation(LT) and ABO-compatible(ABO-C) LT.METHODS A systematic review and meta-analysis were performed by searching eligible articles published before November 28, 2016 on MEDLINE(Pub Med), EMBASE, and Cochrane databases. The primary endpoints were graft survival, patient survival, and ABO-I-related complications. RESULTS Twenty-one retrospective observational studies with a total of 8247 patients were included in this metaanalysis. Pooled results of patient survival for ABO-I LT were comparable to those for ABO-C LT. However, ABO-I LT showed a poorer graft survival than ABO-C LT(1-year: OR = 0.66, 95%CI: 0.57-0.76, P < 0.001; 3-year: OR = 0.74, 95% CI 0.64-0.85, P < 0.001; 5-yearr: OR =0.75, 95%CI: 0.66-0.86, P < 0.001). Furthermore, ABO-I LT was associated with more incidences of antibody-mediated rejection(OR = 74.21, 95%CI: 16.32-337.45, P < 0.001), chronic rejection(OR =2.28, 95%CI: 1.00-5.22, P = 0.05), cytomegalovirus infection(OR = 2.64, 95%CI: 1.63-4.29, P < 0.001), overall biliary complication(OR = 1.52, 95%CI: 1.01-2.28, P = 0.04), and hepatic artery complication(OR = 4.17, 95%CI: 2.26-7.67, P < 0.001) than ABO-C LT. In subgroup analyses, ABO-I LT and ABO-C LT showed a comparable graft survival in pediatric patients and those using rituximab, and ABO-I LT showed an increased acute cellular rejection in cases involving deceased donor grafts.CONCLUSION Although patient survival in ABO-I LT was comparable to that in ABO-C LT, ABO-I LT was inferior to ABO-C LT in graft survival and several complications. Graft survival of ABO-I LT could be comparable to that of ABO-C LT in pediatric patients and those using rituximab. | Eung Chang Lee Seong Hoon Kim Sang-Jae Park | 2017 | World Journal of Gastroenterology2017，23，35： | 5 |
| 5 | A comparison of desensitization methods: Rituximab with/without plasmapheresis in ABO-incompatible living donor liver transplantation显示文摘Background: Plasmapheresis is a desensitization method used prior to ABO-incompatible(ABO-I) living donor liver transplantation. However, studies on its usefulness in the rituximab era are lacking.Methods: Fifty-six adult patients underwent ABO-I living donor liver transplantation between January2012 and October 2015. A single dose of rituximab(300 mg/m^2) was administered 2 weeks before surgery with plasmapheresis in all patients until February 2014(RP group, n = 26). Patients were administered rituximab only, without plasmapheresis between March 2014 and October 2015(RO group, n = 30).Results: The 6-, 12-and 18-month overall survival rates were 92.3%, 80.8% and 76.9% in the RP group and 96.6%, 85.4% and 85.4% in the RO group, respectively(P = 0.574). When the initial isoagglutinin titers < 16, neither group showed a rebound rise of isoagglutinin titers. For patients with initial isoagglutinin titers ≥ 16, the rebound rise of isoagglutinin titers was more prominent in the RP group. There was no difference in time-dependent changes in B cell subpopulations and ABO-I-related complications.Conclusions: Sufficient desensitization for ABO-I living donor liver transplantation can be achieved using rituximab alone. This desensitization strategy does not affect the isoagglutinin titers, ABO-I-related complications and patient survival. | Eung Chang Lee Seong Hoon Kim Jae Ryong Shim Sang-Jae Park | 2018 | Hepatobiliary & Pancreatic Diseases International2018，17，2： | 4 |
| 6 | Local excision after neoadjuvant chemoradiation therapy in advanced rectal cancer: a national multicenter analysis显示文摘 | Chang Sik Yu Hae Ran Yun Eung Jin Shin Kang Yong Lee Nam Kyu Kim Seok-Byung Lim Seong Taek Oh Sung-Bum Kang Won Joon Choi Woo Yong Lee | 2013 | The American Journal of Surgery2013，，： | 2 |
| 7 | Hepatitis B virus X mutations occurring naturally associated with clinical severity of liver disease among Korean patients with chronic genotype C infection显示文摘 | Hyun‐JuKim Joo‐HeePark YoungmeeJee Seoung‐AeLee HongKim Byung‐CheolSong SoohyunYang MyungheeLee Jung‐HwanYoon Yoon JunKim Hyo‐SukLee Eung‐SooHwang Yoon‐HohKook Bum‐JoonKim | 2008 | J. Med. Virol2008，，8： | 2 |
| 8 | Gender disparity in distribution of the major hydrophilic region variants of hepatitis B virus genotype C according to hepatitis B e antigen serostatus显示文摘 | Seoung‐AeLee Yoo‐KyungCho Keun‐HwaLee Eung‐SooHwang Yoon‐HohKook Bum‐JoonKim | 2011 | J Med Virol2011，，3： | 2 |
| 9 | Naturally occurring hepatitis B virus X deletions and insertions among Korean chronic patients显示文摘 | Seoung‐AeLee Ho‐SukMun HongKim Hyung‐KiLee Buyng‐JunKim Eung‐SooHwang Yoon‐HohKook Bum‐JoonKim | 2010 | J. Med. Virol2010，，1： | 2 |
| 10 | Pathologic response to preoperative transarte- rial chemoembolization for resectable hepatocellular carcinoma may not predict recurrence after liver resection显示文摘BACKGROUND: Pathologic response(PR) predicts survival after preoperative chemotherapy and resection of a malignancy. Occasionally, transarterial chemoembolization(TACE)may be selected for preoperative management of resectable hepatocellular carcinoma(HCC). This study investigated whether PR to preoperative TACE can predict recurrence after resection for resectable HCC.METHODS: We conducted analysis of 106 HCC patients who underwent TACE followed by liver resection with a curative intent. The PR was evaluated as the mean percentage of nonviable tumor area within each tumor. We divided the patients into three groups according to response rate: complete PR(CPR), major response(MJR: PR≥50%) and minor response(MNR: PR<50%). The primary endpoint was disease-free survival, and the secondary endpoints were predicting factors for tumor recurrence and MJR+CPR.RESULTS: Among the 121 TACE patients, PR could be measured in 106(87.6%). The mean interval between TACE and liver resection was 33.1 days. The 5-year disease-free survival rates by PR status were as follows: 40.6% CPR, 43.7% MJR, and 49.0% MNR(P=0.815). There were also no significant differences in overall survival between the three groups. Multivariate analyses revealed that microvascular invasion and capsular invasion(hazard ratio [HR]=11.224, P=0.002 and HR=2.220P=0.043) were independent predictors of disease-free survival.Multivariate analysis of the predictors of above 50% PR revealed that only hepatitis B was an independent factor.CONCLUSION: These data could reflect that the PR after TACE for resectable HCC may not be useful for predicting recurrence of HCC after resection. | Kwang Yeol Paik Eung Kook Kim | 2016 | Hepatobiliary & Pancreatic Diseases International2016，15，2： | 2 |
| 11 | Analysis of hepatitis B virus quasispecies distribution in a Korean chronic patient based on the full genome sequences显示文摘 | HongKim Young‐MiJee Byung‐CheolSong Jin‐WonHyun Ho‐SukMun Hyun‐JuKim Eun‐JuOh Jung‐HwanYoon Yoon‐JunKim Hyo‐SukLee Eung‐SooHwang Chang‐YongCha Yoon‐HohKook Bum‐JoonKim | 2007 | J. Med. Virol2007，，3： | 2 |
| 12 | Design &Development of a 15 kV/20 kA HTS fault current limiter显示文摘 | L EUNG E BURLEY B CHITWOOD N | 2000 | IEEE Transactions on applied superconductivity2000，10，1： | 1 |
| 13 | The role of 18F‐FDG‐PET imaging for the selection of liver transplantation candidates among hepatocellular carcinoma patients显示文摘 | Sung Hoon Yang Kyung‐Suk Suh Hae Won Lee Eung‐Ho Cho Jai Young Cho Yong Beom Cho Nam‐Joon Yi Kuhn Uk Lee | 2006 | Liver Transpl2006，，11： | 1 |
| 14 | Use of a stress inducible promoter to drive ectopic AtCBF expression improves potato freezing tolerance while minimizing negative effects on tuber yield显示文摘 | María‐TeresaPino Jeffrey S.Skinner Eung‐JunPark ZoranJekni? Patrick M.Hayes Michael F.Thomashow Tony H. H.Chen | 2007 | Plant Biotechnology Journal2007，，5： | 1 |
| 15 | Naturally occurring hepatitis B virus X deletions and insertions among Korean chronic patients显示文摘 | Seoung‐AeLee Ho‐SukMun HongKim Hyung‐KiLee Buyng‐JunKim Eung‐SooHwang Yoon‐HohKook Bum‐JoonKim | 2010 | J Med Virol2010，，1： | 1 |
| 16 | Dual effects of tetrandrine on cytosolic calcium in human leukaemic HL-60 cells: intracellular calcium release and calcium entry blockade显示文摘 | EUNG YM KWAN CY LOH TT | 1994 | Br J Pharmacol1994，113，3： | 1 |
| 17 | Hepatitis B virus X mutations occurring naturally associated with clinical severity of liver disease among Korean patients with chronic genotype C infection显示文摘 | Hyun‐JuKim Joo‐HeePark YoungmeeJee Seoung‐AeLee HongKim Byung‐CheolSong SoohyunYang MyungheeLee Jung‐HwanYoon Yoon JunKim Hyo‐SukLee Eung‐SooHwang Yoon‐HohKook Bum‐JoonKim | 2008 | J Med Virol2008，，8： | 1 |
| 18 | Expression of basic fibroblast growth factor during distraction osteogenesis显示文摘 | Y eung H Y Lee S K Fung K P | 2001 | Clin Orthop Relat Res2001，385，： | 1 |
| 19 | Heat transfer characteristics of the ice slurry at melting process in a tube flow 显示文摘 | Dong Won Lee Eung Sang Yoon Moon ChangJoo | 2006 | International Journal of Refrigeration2006，29，： | 1 |
| 20 | Analysis of hepatitis B virus quasispecies distribution in a Korean chronic patient based on the full genome sequences显示文摘 | HongKim Young‐MiJee Byung‐CheolSong Jin‐WonHyun Ho‐SukMun Hyun‐JuKim Eun‐JuOh Jung‐HwanYoon Yoon‐JunKim Hyo‐SukLee Eung‐SooHwang Chang‐YongCha Yoon‐HohKook Bum‐JoonKim | 2007 | J Med Virol2007，，3： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员